Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

165
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
165
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

326
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
326
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

132
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
132
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

167
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
167
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

149
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
149
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

269
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
269

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hepatic and intestinal microcirculation and pulmonary inflammation in a model of veno-arterial extracorporeal membrane oxygenation in the rat.

Intensive care medicine experimental·2026
Same author

Biobased and Biodegradable Furandicarboxylate Polyesters: Linking Molecular Structure to Enzymatic Hydrolyzability.

Environmental science & technology·2026
Same author

Concerns regarding methodology, evidentiary basis, and potential industry-related influence in a recent American Association for Thoracic Surgery Expert Consensus Document.

The Journal of thoracic and cardiovascular surgery·2026
Same author

Implementing custom PRO and NPS tools in private practice: balancing simplicity and clinical value in a retrospective study.

Journal of patient-reported outcomes·2026
Same author

Zentralblatt fur Chirurgie·2026
Same author

Risk Reduction by Direct Thrombin Antagonism During ECMO Therapy.

The Thoracic and cardiovascular surgeon·2026

Related Experiment Video

Updated: Dec 9, 2025

Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.1K

Goal-Directed Therapy for Cardiac Surgery.

Kevin W Lobdell1, Subhasis Chatterjee2, Michael Sander3

  • 1Atrium Health Cardiothoracic Surgery, Atrium Health's Carolinas Medical Center, PO Box 32861, Charlotte, NC 28232, USA.

Critical Care Clinics
|September 7, 2020
PubMed
Summary

Goal-directed therapy (GDT) aims to reduce patient risks and improve care quality. Further research is needed to confirm its benefits in cardiac surgery, especially for high-risk individuals.

Keywords:
Acute kidney injuryBiomarkersCardiac surgeryGoal-directed therapyMonitoring

More Related Videos

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

9.8K
Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model
07:20

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model

Published on: February 10, 2023

1.5K

Related Experiment Videos

Last Updated: Dec 9, 2025

Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.1K
Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

9.8K
Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model
07:20

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model

Published on: February 10, 2023

1.5K

Area of Science:

  • Critical care medicine
  • Surgical outcomes research
  • Health services research

Background:

  • Goal-directed therapy (GDT) integrates therapeutic interventions with physiological targets.
  • GDT aims to reduce patient mortality and morbidity by addressing modifiable risks.
  • Current evidence suggests GDT improves quality-of-care metrics like length of stay and readmission rates.

Purpose of the Study:

  • To evaluate the effectiveness of goal-directed therapy in surgical patient populations.
  • To explore the potential benefits of GDT in reducing complications and mortality.
  • To identify optimal parameters and patient profiles for GDT implementation.

Main Methods:

  • Review of existing literature on goal-directed therapy in surgical settings.
  • Analysis of studies demonstrating GDT's impact on quality-of-care metrics.
  • Identification of research gaps concerning GDT in specific surgical fields.

Main Results:

  • Goal-directed therapy has shown promise in reducing complication rates and length of stay in noncardiac surgery.
  • Debate continues regarding specific GDT protocols, target parameters, and patient selection criteria.
  • Existing studies highlight the need for more extensive research in cardiac surgery.

Conclusions:

  • Goal-directed therapy offers potential benefits for surgical patients by optimizing physiological parameters.
  • Demonstrating GDT's efficacy in cardiac surgery requires larger, focused studies, particularly in high-risk populations.
  • Further investigation is crucial to establish robust evidence for GDT's role in improving cardiac surgical outcomes.